CN117136055B - 包含诱导抗老化基因klotho的表达的化合物的用于预防或治疗退行性神经疾病的组合物 - Google Patents
包含诱导抗老化基因klotho的表达的化合物的用于预防或治疗退行性神经疾病的组合物Info
- Publication number
- CN117136055B CN117136055B CN202280026649.3A CN202280026649A CN117136055B CN 117136055 B CN117136055 B CN 117136055B CN 202280026649 A CN202280026649 A CN 202280026649A CN 117136055 B CN117136055 B CN 117136055B
- Authority
- CN
- China
- Prior art keywords
- compound
- cells
- klotho
- gene
- oxazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210042958 | 2021-04-01 | ||
| KR10-2021-0042958 | 2021-04-01 | ||
| KR10-2021-0130307 | 2021-09-30 | ||
| KR1020210130307A KR102375097B1 (ko) | 2021-04-01 | 2021-09-30 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
| PCT/KR2022/004341 WO2022211420A1 (ko) | 2021-04-01 | 2022-03-28 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117136055A CN117136055A (zh) | 2023-11-28 |
| CN117136055B true CN117136055B (zh) | 2026-07-03 |
Family
ID=80936324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280026649.3A Active CN117136055B (zh) | 2021-04-01 | 2022-03-28 | 包含诱导抗老化基因klotho的表达的化合物的用于预防或治疗退行性神经疾病的组合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240358683A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4316487A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7728031B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102375097B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117136055B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022251900B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023019984A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022211420A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102375097B1 (ko) * | 2021-04-01 | 2022-03-17 | 주식회사 클로소사이언스 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
| BR112023020026A2 (pt) * | 2021-04-01 | 2024-01-23 | Klotho Sciences | Composição para prevenir ou tratar doença renal crônica compreendendo compostos que induzem a expressão do gene antienvelhecimento klotho |
| EP4434534A1 (en) | 2023-03-22 | 2024-09-25 | ADvantage Therapeutics, Inc. | Klotho mrna |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088770A (en) * | 1971-05-04 | 1978-05-09 | Eli Lilly And Company | Substituted 2-anilinobenzoxazoles used as immunosuppressive agents |
| KR20110137868A (ko) * | 2010-06-18 | 2011-12-26 | 이화여자대학교 산학협력단 | Interleukin―6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
| KR101446301B1 (ko) * | 2013-04-11 | 2014-10-06 | 서울대학교산학협력단 | Cxcr3/cxcl10 길항제 화합물, 이의 제조방법 및 이를 포함하는 골 전이의 예방 및 치료용 약학 조성물 |
| KR20170024522A (ko) * | 2015-08-24 | 2017-03-07 | 이화여자대학교 산학협력단 | 2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| CN114502541A (zh) * | 2019-10-02 | 2022-05-13 | 克洛索科学公司 | 诱导抗老化基因klotho的表达的化合物及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275210A (en) * | 1971-05-04 | 1981-06-23 | Eli Lilly And Company | Substituted 2-anilinobenzoxazoles |
| US6713474B2 (en) * | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
| EP1388341A1 (en) * | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| US20070066577A1 (en) * | 2003-04-03 | 2007-03-22 | Hea Young Park Choo | Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same |
| US7329682B2 (en) * | 2003-04-03 | 2008-02-12 | Ewha University-Industry Collaboration Foundation | Method for inhibiting 5-lipoxygenase using a benzoxazole derivative |
| MX2007000562A (es) | 2004-07-16 | 2007-03-30 | Univ Columbia | Compuestos y su preparacion para el tratamiento de la enfermedad de alzheimer al inhibir la produccion de peptidos beta-amiloideos. |
| US7345178B2 (en) * | 2005-08-04 | 2008-03-18 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| DE102006021878A1 (de) * | 2006-05-11 | 2007-11-15 | Sanofi-Aventis | Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2010039186A2 (en) * | 2008-09-23 | 2010-04-08 | Renovis, Inc. | Compounds useful as faah modulators and uses thereof |
| WO2010129954A1 (en) * | 2009-05-08 | 2010-11-11 | Apogee Biotechnology Corporation | Treatment of ischemia-reperfusion injury |
| KR20160069736A (ko) * | 2014-12-09 | 2016-06-17 | (주)아모레퍼시픽 | 메틸화된 카테킨을 유효성분으로 함유하는 Klotho 유전자 활성화용 조성물 |
| EP3253403B1 (en) * | 2015-02-06 | 2021-09-01 | The Regents of The University of California | Methods and compositions for improved cognition |
| WO2016176473A1 (en) * | 2015-04-28 | 2016-11-03 | Sanford-Burnham Medical Researc Institute | Apelin receptor agonists and methods of use thereof |
| KR102064611B1 (ko) * | 2017-10-13 | 2020-01-09 | 이화여자대학교 산학협력단 | 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
| CN112703164A (zh) | 2018-09-26 | 2021-04-23 | 三菱电机大楼技术服务株式会社 | 电梯系统以及便携式终端 |
| US12134772B2 (en) * | 2018-11-21 | 2024-11-05 | Advantage Therapeutics, Inc. | Increasing gene expression |
| US11446488B2 (en) * | 2019-03-13 | 2022-09-20 | Leonhardt Ventures Llc | Kidney treatment |
| KR102749973B1 (ko) | 2020-04-21 | 2025-01-06 | 엘지마그나 이파워트레인 주식회사 | 전기모터 및 이를 구비한 전기차량 |
| KR102375097B1 (ko) * | 2021-04-01 | 2022-03-17 | 주식회사 클로소사이언스 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
| BR112023020026A2 (pt) * | 2021-04-01 | 2024-01-23 | Klotho Sciences | Composição para prevenir ou tratar doença renal crônica compreendendo compostos que induzem a expressão do gene antienvelhecimento klotho |
-
2021
- 2021-09-30 KR KR1020210130307A patent/KR102375097B1/ko active Active
-
2022
- 2022-03-28 CN CN202280026649.3A patent/CN117136055B/zh active Active
- 2022-03-28 JP JP2023561185A patent/JP7728031B2/ja active Active
- 2022-03-28 WO PCT/KR2022/004341 patent/WO2022211420A1/ko not_active Ceased
- 2022-03-28 AU AU2022251900A patent/AU2022251900B2/en active Active
- 2022-03-28 US US18/553,414 patent/US20240358683A1/en active Pending
- 2022-03-28 EP EP22781539.6A patent/EP4316487A4/en active Pending
- 2022-03-28 BR BR112023019984A patent/BR112023019984A2/pt unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088770A (en) * | 1971-05-04 | 1978-05-09 | Eli Lilly And Company | Substituted 2-anilinobenzoxazoles used as immunosuppressive agents |
| KR20110137868A (ko) * | 2010-06-18 | 2011-12-26 | 이화여자대학교 산학협력단 | Interleukin―6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
| KR101446301B1 (ko) * | 2013-04-11 | 2014-10-06 | 서울대학교산학협력단 | Cxcr3/cxcl10 길항제 화합물, 이의 제조방법 및 이를 포함하는 골 전이의 예방 및 치료용 약학 조성물 |
| KR20170024522A (ko) * | 2015-08-24 | 2017-03-07 | 이화여자대학교 산학협력단 | 2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| CN114502541A (zh) * | 2019-10-02 | 2022-05-13 | 克洛索科学公司 | 诱导抗老化基因klotho的表达的化合物及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022211420A1 (ko) | 2022-10-06 |
| AU2022251900B2 (en) | 2025-09-18 |
| US20240358683A1 (en) | 2024-10-31 |
| JP2024512818A (ja) | 2024-03-19 |
| EP4316487A4 (en) | 2025-04-09 |
| AU2022251900A9 (en) | 2023-11-09 |
| AU2022251900A1 (en) | 2023-10-26 |
| KR102375097B1 (ko) | 2022-03-17 |
| JP7728031B2 (ja) | 2025-08-22 |
| BR112023019984A2 (pt) | 2024-04-02 |
| CA3213904A1 (en) | 2022-10-06 |
| EP4316487A1 (en) | 2024-02-07 |
| CN117136055A (zh) | 2023-11-28 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |